AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteTrimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.
More Information Supplier PageTrimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageTrimipramine (Surmontil, Rhotrimine, Stangyl) is a tricyclic antidepressant (TCA). It has antidepressant, anxiolytic, antipsychotic, sedative, and analgesic effects
More Information Supplier PageTrimipramine (Surmontil, Rhotrimine, Stangyl) is a tricyclic antidepressant (TCA). It has antidepressant, anxiolytic, antipsychotic, sedative, and analgesic effects
More Information Supplier PageTrimipramine (Surmontil, Rhotrimine, Stangyl) is a tricyclic antidepressant (TCA). It has antidepressant, anxiolytic, antipsychotic, sedative, and analgesic effects
More Information Supplier PageTrimipramine (Surmontil, Rhotrimine, Stangyl) is a tricyclic antidepressant (TCA). It has antidepressant, anxiolytic, antipsychotic, sedative, and analgesic effects
More Information Supplier PageTriphendiol (NV-196) is a synthetic isoflavene. Triphendiol (NV-196) is another investigational drug in the Marshall Edwards, Inc., oncology drug pipeline. Triphendiol is broadly cytostatic and cytotoxic against most forms of human cancer cells in vitro, and has been shown to cause cell cycle arrest (or stop cells increasing in number) and to induce apoptosis (or […]
More Information Supplier PageTriphendiol (NV-196) is a synthetic isoflavene. Triphendiol (NV-196) is another investigational drug in the Marshall Edwards, Inc., oncology drug pipeline. Triphendiol is broadly cytostatic and cytotoxic against most forms of human cancer cells in vitro, and has been shown to cause cell cycle arrest (or stop cells increasing in number) and to induce apoptosis (or […]
More Information Supplier PageTriphendiol (NV-196) is a synthetic isoflavene. Triphendiol (NV-196) is another investigational drug in the Marshall Edwards, Inc., oncology drug pipeline. Triphendiol is broadly cytostatic and cytotoxic against most forms of human cancer cells in vitro, and has been shown to cause cell cycle arrest (or stop cells increasing in number) and to induce apoptosis (or […]
More Information Supplier PageTriphendiol (NV-196) is a synthetic isoflavene. Triphendiol (NV-196) is another investigational drug in the Marshall Edwards, Inc., oncology drug pipeline. Triphendiol is broadly cytostatic and cytotoxic against most forms of human cancer cells in vitro, and has been shown to cause cell cycle arrest (or stop cells increasing in number) and to induce apoptosis (or […]
More Information Supplier PageTriptonide is a Triptolide analogue used in the preparation of cytotoxic fluorinated Triptolide.
More Information Supplier PageTriptonide is a Triptolide analogue used in the preparation of cytotoxic fluorinated Triptolide.
More Information Supplier PageTriptonide is a Triptolide analogue used in the preparation of cytotoxic fluorinated Triptolide.
More Information Supplier PageTriptophenolide and its related compounds from Tripterygium wilfordii Hook.f is a kind of diterpenoids which shows anti-inflammatory activity.
More Information Supplier PageTriptophenolide and its related compounds from Tripterygium wilfordii Hook.f is a kind of diterpenoids which shows anti-inflammatory activity.
More Information Supplier PageTriptophenolide and its related compounds from Tripterygium wilfordii Hook.f is a kind of diterpenoids which shows anti-inflammatory activity.
More Information Supplier PageTroglitazone is a selective PPAR?? receptor agonist (EC50 values are 780 and 555 nM at murine and human PPAR?? receptors respectively).
More Information Supplier PageTroglitazone is a selective PPAR?? receptor agonist (EC50 values are 780 and 555 nM at murine and human PPAR?? receptors respectively).
More Information Supplier PageTroglitazone is a selective PPAR?? receptor agonist (EC50 values are 780 and 555 nM at murine and human PPAR?? receptors respectively).
More Information Supplier PageTroglitazone is a selective PPAR?? receptor agonist (EC50 values are 780 and 555 nM at murine and human PPAR?? receptors respectively).
More Information Supplier PageTropanserin acts as a potent and selective 5-HT3 receptor antagonist.
More Information Supplier PageTropanserin acts as a potent and selective 5-HT3 receptor antagonist.
More Information Supplier PageTropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy.
More Information Supplier PageTropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy.
More Information Supplier PageTropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy.
More Information Supplier PageTropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy.
More Information Supplier PageTropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy.
More Information Supplier PageTropisetron is a selective 5-HT3 receptor antagonist and ??7-nicotinic receptor agonist with an IC50 of 70.1 ?? 0.9 nM for 5-HT3 receptor.
More Information Supplier PageTropisetron is a selective 5-HT3 receptor antagonist and ??7-nicotinic receptor agonist with an IC50 of 70.1 ?? 0.9 nM for 5-HT3 receptor.
More Information Supplier PageTropisetron is a selective 5-HT3 receptor antagonist and ??7-nicotinic receptor agonist with an IC50 of 70.1 ?? 0.9 nM for 5-HT3 receptor.
More Information Supplier PageTroxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
More Information Supplier PageTroxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
More Information Supplier PageTroxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
More Information Supplier PageTroxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
More Information Supplier PageTroxerutin(Trihydroxyethylrutin) is a flavonol, a type of flavonoid. It is more accurately a hydroxyethylrutoside. It can be isolated from Sophora japonica, the japanese pagoda tree.It is used as a vasoprotective.
More Information Supplier PageTroxerutin(Trihydroxyethylrutin) is a flavonol, a type of flavonoid. It is more accurately a hydroxyethylrutoside. It can be isolated from Sophora japonica, the japanese pagoda tree.It is used as a vasoprotective.
More Information Supplier PageTRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less ??-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.
More Information Supplier PageTRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less ??-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.
More Information Supplier PageTRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less ??-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.
More Information Supplier PageTRV 130 HCl is a novel ??-opioid receptor (MOR) G protein-biased ligand; elicits robust G protein signaling(pEC50=8.1), with potency and efficacy similar to morphine, but with far less beta-arrestin recruitment and receptor internalization.
More Information Supplier PageTRV 130 HCl is a novel ??-opioid receptor (MOR) G protein-biased ligand; elicits robust G protein signaling(pEC50=8.1), with potency and efficacy similar to morphine, but with far less beta-arrestin recruitment and receptor internalization.
More Information Supplier PageTRV 130 HCl is a novel ??-opioid receptor (MOR) G protein-biased ligand; elicits robust G protein signaling(pEC50=8.1), with potency and efficacy similar to morphine, but with far less beta-arrestin recruitment and receptor internalization.
More Information Supplier PageTSU-68 (SU-6668) is an inhibitor of RTKs involved in VEGF, bFGF and PDGF signaling, which inhibits endothelial cell proliferation.
More Information Supplier PageTSU-68 (SU-6668) is an inhibitor of RTKs involved in VEGF, bFGF and PDGF signaling, which inhibits endothelial cell proliferation.
More Information Supplier Page
